Clinical Trials Browser

Neuroinflammatory Diseases, Hypoxia, Brain Neoplasms

NCT05376566 2026-03-24

Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections

Phase NA Completed

212 enrolled

Neoplasms, Sepsis

NCT03142334 2026-03-10

KEYNOTE-564

Phase 3 Completed

994 enrolled 10 charts 2 FDA

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Renal Cell

NCT03221426 2026-03-09

KEYNOTE-585

Phase 3 Completed

1,007 enrolled 25 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT04882241 2026-03-06

KEYNOTE-585

Phase 3 Completed

120 enrolled 17 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT07445451 2026-03-03

TURBT

Phase NA Completed

93 enrolled

Genitourinary

Urinary Bladder Neoplasms, Pain, Postoperative

NCT05640817 2026-02-06

Nephroprotective Effect of Pentoxifylline Against Cisplatin in Patients With Head and Neck Cancer

Phase NA Completed

90 enrolled

Pentoxifylline, Cisplatin, Nephrotoxixcity

NCT03635567 2026-02-04

KEYNOTE-826

Phase 3 Completed

617 enrolled 29 charts 2 FDA

Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT07385898 2026-02-04

Dex

Phase NA Completed

64 enrolled

Gastrointestinal

Rectal Neoplasms, Sigmoid Neoplasms, Lung Injury

Clinical Trials

Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome

Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections

KEYNOTE-564

KEYNOTE-585

KEYNOTE-585

TURBT

Nephroprotective Effect of Pentoxifylline Against Cisplatin in Patients With Head and Neck Cancer

KEYNOTE-826

Dex